TRV GP V, LLC
Insider CIK 1990717 · MAZE 10% owner · CRGX 10% owner · SEPN 10% owner · RAPP 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SEPN Septerna, Inc. | S Sale | 2026-08-12 | 2026-08-14 | 147,059 | $50.27 | $7.39M | 6,068,532 | SEC↗ |
| SEPN Septerna, Inc. | S Sale | 2026-08-12 | 2026-08-14 | 141 | $51.08 | $7.2K | 6,068,391 | SEC↗ |
| SEPN Septerna, Inc. | S Sale | 2026-08-12 | 2026-08-14 | 141 | $51.08 | $7.2K | 6,068,391 | SEC↗ |
| SEPN Septerna, Inc. | S Sale | 2026-08-12 | 2026-08-14 | 147,059 | $50.27 | $7.39M | 6,068,532 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-05-26 | 2026-05-28 | 18,572 | $40.05 | $743.8K | 6,280,525 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-05-11 | 2026-05-13 | 133,618 | $40.24 | $5.38M | 6,299,097 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-05-08 | 2026-05-11 | 5,018 | $40.31 | $202.3K | 6,432,715 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-05-07 | 2026-05-11 | 271,495 | $40.12 | $10.89M | 6,437,733 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | S Sale | 2026-04-17 | 2026-04-21 | 426,005 | $40.32 | $17.18M | 6,709,228 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | J Other | 2025-11-04 | 2025-11-05 | 1,600,000 | — | $0 | 4,473,958 | SEC↗ |
| SEPN Septerna, Inc. | P Buy | 2025-02-24 | 2025-02-26 | 18,861 | $6.00 | $113.2K | 4,211,659 | SEC↗ |
| SEPN Septerna, Inc. | P Buy | 2025-02-21 | 2025-02-24 | 427,668 | $5.94 | $2.54M | 4,192,798 | SEC↗ |
| SEPN Septerna, Inc. | P Buy | 2025-02-20 | 2025-02-24 | 612,674 | $5.92 | $3.63M | 3,765,130 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | C Conversion deriv | 2025-02-03 | 2025-02-04 | 9,725,709 | — | $0 | 0 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | C Conversion deriv | 2025-02-03 | 2025-02-04 | 9,166,666 | — | $0 | 0 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | C Conversion deriv | 2025-02-03 | 2025-02-04 | 45,833,334 | — | $0 | 0 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | C Conversion | 2025-02-03 | 2025-02-04 | 5,762,788 | — | $0 | 6,073,958 | SEC↗ |
| MAZE Maze Therapeutics, Inc. | C Conversion | 2025-02-03 | 2025-02-04 | 950,800 | — | $0 | 950,800 | SEC↗ |
| SEPN Septerna, Inc. | C Conversion deriv | 2024-10-28 | 2024-10-28 | 24,737,017 | — | $0 | 0 | SEC↗ |
| SEPN Septerna, Inc. | C Conversion deriv | 2024-10-28 | 2024-10-28 | 41,250,000 | — | $0 | 0 | SEC↗ |
| SEPN Septerna, Inc. | P Buy | 2024-10-28 | 2024-10-28 | 279,500 | $18.00 | $5.03M | 3,152,456 | SEC↗ |
| SEPN Septerna, Inc. | C Conversion | 2024-10-28 | 2024-10-28 | 2,872,956 | — | $0 | 2,872,956 | SEC↗ |
| SEPN Septerna, Inc. | P Buy | 2024-10-28 | 2024-10-28 | 370,500 | $18.00 | $6.67M | 6,215,591 | SEC↗ |
| SEPN Septerna, Inc. | C Conversion | 2024-10-28 | 2024-10-28 | 4,790,773 | — | $0 | 5,845,091 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | C Conversion deriv | 2024-06-10 | 2024-06-10 | 56,091,177 | — | $0 | 0 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | C Conversion deriv | 2024-06-10 | 2024-06-10 | 8,000,000 | — | $0 | 0 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | C Conversion deriv | 2024-06-10 | 2024-06-10 | 298,103 | — | $0 | 0 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | C Conversion | 2024-06-10 | 2024-06-10 | 969,218 | — | $0 | 969,218 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | C Conversion | 2024-06-10 | 2024-06-10 | 6,551,449 | — | $0 | 7,135,233 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | C Conversion deriv | 2023-11-14 | 2023-11-14 | 23,571,429 | — | $0 | 0 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | C Conversion deriv | 2023-11-14 | 2023-11-14 | 6,428,571 | — | $0 | 0 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | C Conversion | 2023-11-14 | 2023-11-14 | 1,737,216 | — | $0 | 1,737,216 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | P Buy | 2023-11-14 | 2023-11-14 | 1,333,333 | $15.00 | $20.00M | 1,807,119 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | C Conversion | 2023-11-14 | 2023-11-14 | 473,786 | — | $0 | 473,786 | SEC↗ |